AMTX
Aemetis, Inc.
NasdaqGMUSDEQUITY
Basic Materials
DELAYED
Sell
-39/100
Last price
1.79
▲ 0.03 (1.70%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
1.76
Day high
1.80
Day low
1.74
Volume
382.57K
Market cap
$129.18M
P/E (TTM)
—
52W range
1.30 – 3.80
Trailing performance
Returnvs SPY
1W
-2.19%
-4.1%
1M
-2.19%
-3.3%
3M
+1.70%
-2.8%
6M
-38.91%
-57.1%
YTD
+28.78%
+14.5%
1Y
-32.45%
-48.9%
3Y
-56.87%
-139.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on AMTX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.02M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 10, 26 | SIMON TIMOTHY ALAN Director |
SELL | 10.00K | $20.50K | Direct |
| Mar 19, 26 | BLOCK JOHN R Director |
STOCK | 10.00K | $26.40K | Direct |
| Mar 19, 26 | MCAFEE ERIC A Chief Executive Officer |
STOCK | 300.00K | $792.00K | Direct |
| Jan 22, 26 | BLOCK JOHN R Director |
STOCK | 12.00K | $18.48K | Direct |
| Jan 22, 26 | BARTON FRANCIS P Director |
STOCK | 18.00K | $27.72K | Direct |
| Jan 22, 26 | BEEBE LYDIA I Director |
STOCK | 14.50K | $22.33K | Direct |
| Jan 22, 26 | BONESS NAOMI LOUISE Director |
STOCK | 12.00K | $18.48K | Direct |
| Jan 22, 26 | SIMON TIMOTHY ALAN Director |
STOCK | 12.00K | $18.48K | Direct |
| Aug 14, 25 | BARTON FRANCIS P Director |
SELL | 26.45K | $67.02K | Direct |
| May 15, 25 | ROCKETT JAMES MICHAEL General Counsel |
STOCK | 27.92K | $45.51K | Direct |
| Apr 7, 25 | WALTZ TODD Chief Financial Officer |
CONVERSION | 288.88K | $207.28K | Direct |
| Jan 16, 25 | BLOCK JOHN R Director |
STOCK | 12.00K | $0 | Direct |
| Jan 16, 25 | BARTON FRANCIS P Director |
STOCK | 18.00K | $0 | Direct |
| Jan 16, 25 | MCAFEE ERIC A Chief Executive Officer |
STOCK | 300.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARTON FRANCIS P |
Director | 226.52K | Stock Award(Grant) |
BEEBE LYDIA I |
Director | 214.29K | Stock Award(Grant) |
BLOCK JOHN R |
Director | 56.33K | Stock Award(Grant) |
BONESS NAOMI LOUISE |
Director | 64.64K | Stock Award(Grant) |
MCAFEE ERIC A |
Chief Executive Officer | 3.92M | Stock Award(Grant) |
ROCKETT JAMES MICHAEL |
General Counsel | 27.92K | Stock Award(Grant) |
SIMON TIMOTHY ALAN |
Director | 42.63K | Sale |
WALTZ TODD |
Chief Financial Officer | 456.82K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$129.18M
Enterprise value$680.34M
Revenue (TTM)$230.17M
Gross profit$23.94M
EBITDA$-1.58M
Net income$-60.16M
EPS (TTM)$-0.86
Free cash flow$-65.83M
Total cash$973.00K
Total debt$552.13M
Book value / share$-4.47
Shares outstanding72.17M
Float67.16M
Short % of float13.72%
Dividend yield0.00%
Beta (5Y)1.82
Valuation & profitability ratios
Trailing P/E—
Forward P/E-3.51
PEG ratio—
Price / sales—
Price / book—
EV / revenue2.96
EV / EBITDA-431.42
Gross margin10.40%
Operating margin9.21%
Profit margin-26.14%
Return on equity—
Return on assets-2.73%
Debt / equity—
Current ratio0.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $207.98M | $267.64M | $186.72M | $256.51M | — | -22.3% |
| Operating revenue | $207.98M | $267.64M | $186.72M | $256.51M | — | -22.3% |
| Cost of revenue | $208.75M | $268.22M | $184.70M | $262.05M | — | -22.2% |
| Gross profit | -$768.00K | -$580.00K | $2.02M | -$5.54M | — | -32.4% |
| Research & development | — | — | $152.00K | $180.00K | $88.00K | — |
| Selling, general & admin | $36.45M | $39.84M | $39.42M | $28.69M | — | -8.5% |
| Total operating expense | $36.45M | $39.84M | $39.42M | $28.87M | — | -8.5% |
| Operating income | -$37.22M | -$40.42M | -$37.40M | -$34.40M | — | +7.9% |
| Net interest income | -$61.14M | -$59.32M | -$64.83M | -$38.66M | — | -3.1% |
| Pre-tax income | -$95.75M | -$98.37M | -$100.16M | -$106.70M | — | +2.7% |
| Tax provision | -$18.75M | -$10.83M | -$53.74M | $1.05M | — | -73.1% |
| Net income | -$77.00M | -$87.54M | -$46.42M | -$107.76M | — | +12.0% |
| Net income to common | -$77.00M | -$87.54M | -$46.42M | -$107.76M | — | +12.0% |
| Basic EPS | -1.28 | -1.91 | -1.22 | -3.12 | — | +33.0% |
| Diluted EPS | -1.28 | -1.91 | -1.22 | -3.12 | — | +33.0% |
| EBIT | -$41.32M | -$45.51M | -$41.85M | -$75.41M | — | +9.2% |
| EBITDA | -$31.69M | -$37.13M | -$34.84M | -$69.83M | — | +14.6% |
| Basic shares | 59.98M | 45.90M | 38.06M | 34.59M | — | +30.7% |
| Diluted shares | 59.98M | 45.90M | 38.06M | 34.59M | — | +30.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.89M | $898.00K | $2.67M | $4.31M | +445.0% |
| Cash & short-term investments | $4.89M | $898.00K | $2.67M | $4.31M | +445.0% |
| Accounts receivable | $484.00K | $1.80M | $8.63M | $1.26M | -73.2% |
| Inventory | $11.63M | $25.44M | $18.29M | $4.66M | -54.3% |
| Total current assets | $26.87M | $44.70M | $36.40M | $18.14M | -39.9% |
| Property, plant & equipment | $206.54M | $186.20M | $181.73M | $167.45M | +10.9% |
| Total assets | $259.84M | $259.30M | $243.41M | $207.11M | +0.2% |
| Total current liabilities | $371.26M | $143.97M | $84.39M | $88.28M | +157.9% |
| Current debt | $317.87M | $90.53M | $37.03M | $49.22M | +251.1% |
| Long-term debt | $63.90M | $247.53M | $257.69M | $197.02M | -74.2% |
| Total debt | $381.76M | $338.06M | $294.72M | $248.77M | +12.9% |
| Total liabilities | $566.67M | $523.23M | $460.38M | $408.97M | +8.3% |
| Retained earnings | -$639.94M | -$562.94M | -$475.40M | -$428.99M | -13.7% |
| Shareholder equity | -$306.83M | -$263.93M | -$216.98M | -$201.85M | -16.3% |
| Working capital | -$344.39M | -$99.27M | -$47.99M | -$70.14M | -246.9% |
| Net tangible assets | -$306.83M | -$263.93M | -$216.98M | -$201.85M | -16.3% |
| Shares issued | 66.19M | 51.14M | 40.97M | 35.87M | +29.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$77.00M | -$87.54M | -$46.42M | -$107.76M | — | +12.0% |
| Depreciation & amortisation | $9.63M | $8.39M | $7.00M | $5.58M | — | +14.8% |
| Stock-based compensation | $5.77M | $8.31M | $7.66M | $6.41M | — | -30.6% |
| Change in working capital | $50.32M | $15.21M | $14.08M | $6.05M | — | +230.9% |
| Operating cash flow | $3.26M | -$32.93M | $13.82M | -$22.87M | — | +109.9% |
| Capital expenditure | -$26.00M | -$20.25M | -$33.12M | -$39.16M | — | -28.4% |
| Investing cash flow | -$25.59M | -$14.15M | -$23.69M | -$31.31M | — | -80.9% |
| Share buybacks | — | $0 | -$30.00M | $0 | -$300.00K | — |
| Financing cash flow | $26.41M | $44.62M | $9.09M | $53.63M | — | -40.8% |
| Free cash flow | -$22.74M | -$53.18M | -$19.29M | -$62.02M | — | +57.2% |
| End cash position | $7.89M | $3.83M | $6.28M | $7.00M | — | +105.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $62.70M | $54.62M | $53.66M | $59.19M | $52.24M | +14.8% |
| Operating revenue | $62.70M | $54.62M | $53.66M | $59.19M | $52.24M | +14.8% |
| Cost of revenue | $49.19M | $51.86M | $45.94M | $59.25M | $55.60M | -5.2% |
| Gross profit | $13.52M | $2.76M | $7.72M | -$58.00K | -$3.35M | +390.4% |
| Selling, general & admin | $7.74M | $9.09M | $10.21M | $8.45M | $7.32M | -14.8% |
| Total operating expense | $7.74M | $9.09M | $10.21M | $8.45M | $7.32M | -14.8% |
| Operating income | $5.77M | -$6.33M | -$2.48M | -$8.51M | -$10.67M | +191.1% |
| Net interest income | -$15.17M | -$15.99M | -$15.82M | -$14.98M | -$14.36M | +5.1% |
| Pre-tax income | -$9.37M | -$21.84M | -$16.77M | -$23.74M | -$23.92M | +57.1% |
| Tax provision | $0 | -$131.00K | -$11.44M | $6.00K | -$529.00K | +100.0% |
| Net income | -$9.37M | -$21.71M | -$5.33M | -$23.75M | -$23.39M | +56.9% |
| Net income to common | -$9.37M | -$21.71M | -$5.33M | -$23.75M | -$23.39M | +56.9% |
| Basic EPS | -0.13 | -0.33 | -0.08 | -0.37 | -0.41 | +60.6% |
| Diluted EPS | -0.13 | -0.33 | -0.08 | -0.37 | -0.41 | +60.6% |
| EBIT | $5.45M | -$7.83M | -$2.83M | -$9.82M | -$10.66M | +169.6% |
| EBITDA | $8.00M | -$5.29M | -$270.00K | -$7.48M | -$8.29M | +251.1% |
| Basic shares | 70.89M | 66.80M | 65.78M | 63.70M | 57.68M | +6.1% |
| Diluted shares | 70.89M | 66.80M | 65.78M | 63.70M | 57.68M | +6.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $973.00K | $4.80M | $4.89M | $5.58M | $1.65M | -79.7% |
| Cash & short-term investments | $973.00K | $4.80M | $4.89M | $5.58M | $1.65M | -79.7% |
| Accounts receivable | $2.31M | $6.58M | $484.00K | $1.65M | $2.70M | -64.8% |
| Inventory | $13.64M | $10.38M | $11.63M | $4.78M | $12.37M | +31.3% |
| Total current assets | $32.99M | $34.69M | $26.87M | $15.55M | $20.09M | -4.9% |
| Property, plant & equipment | $229.43M | $209.46M | $206.54M | $196.90M | $191.70M | +9.5% |
| Total assets | $289.18M | $270.33M | $259.84M | $241.12M | $240.02M | +7.0% |
| Total current liabilities | $415.03M | $396.25M | $371.26M | $343.37M | $321.93M | +4.7% |
| Current debt | $354.18M | $342.63M | $317.87M | $286.71M | $270.61M | +3.4% |
| Long-term debt | $61.72M | $62.05M | $63.90M | $66.79M | $73.62M | -0.5% |
| Total debt | $415.89M | $404.68M | $381.76M | $353.50M | $344.23M | +2.8% |
| Total liabilities | $611.29M | $591.47M | $566.67M | $545.97M | $529.27M | +3.4% |
| Retained earnings | -$671.02M | -$661.66M | -$639.94M | -$634.61M | -$610.87M | -1.4% |
| Shareholder equity | -$322.11M | -$321.14M | -$306.83M | -$304.85M | -$289.25M | -0.3% |
| Working capital | -$382.04M | -$361.56M | -$344.39M | -$327.81M | -$301.84M | -5.7% |
| Net tangible assets | -$322.11M | -$321.14M | -$306.83M | -$304.85M | -$289.25M | -0.3% |
| Shares issued | 72.05M | 69.28M | 66.19M | 65.00M | 61.99M | +4.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$9.37M | -$21.71M | -$5.33M | -$23.75M | -$23.39M | — | +56.9% |
| Depreciation & amortisation | $2.54M | $2.54M | $2.56M | $2.34M | $2.36M | — | +0.4% |
| Stock-based compensation | $1.12M | $1.70M | $795.00K | $1.28M | $1.38M | — | -34.2% |
| Change in working capital | $1.76M | $3.00M | $4.52M | $20.00M | $10.74M | — | -41.4% |
| Operating cash flow | -$1.88M | -$10.56M | $5.77M | $3.07M | -$5.74M | — | +82.2% |
| Capital expenditure | -$8.54M | -$6.55M | -$16.56M | -$4.09M | -$3.52M | — | -30.3% |
| Investing cash flow | -$8.54M | -$5.11M | -$16.56M | -$4.09M | -$3.11M | — | -67.2% |
| Share buybacks | — | $0 | — | — | — | -$2.20M | — |
| Financing cash flow | $7.06M | $14.70M | $10.01M | $5.13M | $10.02M | — | -52.0% |
| Free cash flow | -$10.42M | -$17.11M | -$10.79M | -$1.02M | -$9.26M | — | +39.1% |
| End cash position | $3.52M | $6.87M | $7.89M | $8.55M | $4.59M | — | -48.8% |
Options analytics
Put / call volume
0.22
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
1.00
-44.1% from spot
ATM implied vol
25.0%
Nearest strike to spot
Skew (10% OTM)
+25.0%
Puts bid over calls
Call volume
144
Contracts, this expiry
Put volume
32
Contracts, this expiry
Heaviest call OI
0.50
0 contracts
Heaviest put OI
1.00
3 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.24 | -0.11 | +54.8% |
| Mar 2026 | -0.20 | -0.30 | -47.1% |
| Dec 2025 | -0.22 | -0.09 | +61.2% |
| Sep 2025 | -0.21 | -0.37 | -77.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.18 | 1 | $71.25M | +20.4% |
| Next quarter | -0.19 | 1 | $71.14M | +64.3% |
| Current year | -0.85 | 1 | $259.69M | +31.4% |
| Next year | -0.51 | 2 | $374.19M | +44.1% |
Analyst targets & ownership
Mean target$13.38
High target$28.00
Low target$2.50
Implied upside647.21%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders6.95%
Held by institutions24.65%
Institutions holding115
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.79
-0.08% from price
SMA 20
1.89
-5.27% from price
SMA 50
1.81
-0.92% from price
SMA 100
1.88
-5.04% from price
SMA 200
1.98
-9.39% from price
EMA 12
1.82
-1.50% from price
EMA 26
1.84
-2.90% from price
EMA 50
1.85
-3.28% from price
RSI (14)
46.6
Neutral
MACD (12,26,9)
-0.03
Hist -0.02
ATR (14)
0.13
7.31% of price
Realised vol 30D
71.2%
Annualised
Bollinger upper
2.15
20, 2σ
Bollinger lower
1.63
20, 2σ
50 / 200 cross
Death
1.81 vs 1.98
Trend bias
Below 200
-9.39%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.74
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
71.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-61.5%
Peak to trough
Max drawdown 5Y
-94.4%
Peak to trough
ATR 14
0.13
7.31% of price
Beta (reported)
1.82
5Y monthly, from filing
Short interest
Shares short
9.21M
Prior 8.66M
Change vs prior
+6.4%
Shorts adding
% of float
13.72%
Elevated
% of shares out
12.77%
Against total outstanding
Days to cover
12.0
Crowded exit
Float
67.16M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 22, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Apr 8, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Nov 19, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Oct 6, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Jun 30, 25 | UBS | MAINTAINED | Buy | Buy |
| Jun 6, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 9, 25 | UBS | MAINTAINED | Buy | Buy |
| Mar 17, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Mar 14, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 23, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 15, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split4:1
Split dateJun 15, 2016
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-05-26
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-07
Periodic Financial Reports
10-K · 2026-03-16
Corporate Changes & Voting Matters
8-K · 2026-03-12
Corporate Changes & Voting Matters
8-K · 2026-02-19
Corporate Changes & Voting Matters
8-K · 2026-02-06
Headlines
3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI
Schaeffer's Investment Research · 9d ago
Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits
GlobeNewswire · 9d ago
Aemetis Praises Unanimous Legislative Passage of California E15 Implementation Legislation
GlobeNewswire · 35d ago
Will Alto Ingredients' Higher Maintenance Costs Pressure Margins?
Zacks · 37d ago
Can Alto Ingredients Sustain Gains as Alcohol Premiums Narrow?
Zacks · 44d ago
Can Alto Ingredients' Export Challenges Weigh on Growth Outlook?
Zacks · 51d ago
Aemetis (AMTX) Q2 2026 Earnings Call Transcript
Motley Fool · 55d ago
Stonegate Capital Partners Updates Coverage on Aemetis Inc. (AMTX) 2Q26
TMX Newsfile · 58d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.